Microbix Biosystems Company Executives
| MBX Stock | CAD 0.24 0.01 4.00% |
Microbix Biosystems employs about 15 people. The company is managed by 15 executives with a total tenure of roughly 139 years, averaging almost 9.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Microbix Biosystems' management performance can provide insight into the firm performance.
| Cameron Groome CEO President, Chief Executive Officer, Director |
| Vaughn EmbroPantalony CEO President CEO, Director |
Microbix |
Microbix Biosystems Management Team Effectiveness
The company has return on total asset (ROA) of (0.0261) % which means that it has lost $0.0261 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0801) %, meaning that it generated substantial loss on money invested by shareholders. Microbix Biosystems' management efficiency ratios could be used to measure how well Microbix Biosystems manages its routine affairs as well as how well it operates its assets and liabilities. As of the 16th of January 2026, Return On Tangible Assets is likely to drop to -0.06. In addition to that, Return On Capital Employed is likely to drop to -0.04. At this time, Microbix Biosystems' Asset Turnover is very stable compared to the past year.As of the 16th of January 2026, Common Stock Shares Outstanding is likely to grow to about 168 M, though Net Loss is likely to grow to (2.5 M). Microbix Biosystems maintains a total of 138.81 Million outstanding shares. Microbix Biosystems secures 14.48 % of its outstanding shares held by insiders and 0.0 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 1996-12-31 | Previous Quarter 140.6 M | Current Value 139.3 M | Avarage Shares Outstanding 69.4 M | Quarterly Volatility 38.9 M |
Microbix Biosystems Workforce Comparison
Microbix Biosystems is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 493. Microbix Biosystems adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Microbix Biosystems Profit Margins
The company has Profit Margin (PM) of (0.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.38) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.38.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.63 | 0.61 |
|
|
Microbix Biosystems Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Microbix Biosystems Price Series Summation is a cross summation of Microbix Biosystems price series and its benchmark/peer.
Microbix Biosystems Notable Stakeholders
A Microbix Biosystems stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Microbix Biosystems often face trade-offs trying to please all of them. Microbix Biosystems' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Microbix Biosystems' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Cameron Groome | President, Chief Executive Officer, Director | Profile | |
| Vaughn EmbroPantalony | President CEO, Director | Profile | |
| William Gastle | Founder, Executive Chairman, Member of Audit Committee and Member of HR, Compensation and Governance Committee | Profile | |
| Martin Marino | Independent Chairman of the Board | Profile | |
| Philip Casselli | Senior Vice President - Business Development and Sales, Marketing | Profile | |
| Kathryn Froh | Vice President - Diagnostics | Profile | |
| James Currie | Chief Financial Officer | Profile | |
| Kenneth Hughes | Chief Operating Officer | Profile | |
| Mark Cochran | Independent Director | Profile | |
| Joseph Renner | Lead, Independent Director | Profile | |
| Peter Blecher | Independent Director | Profile | |
| Kevin Cassidy | Senior Vice President Sales and Business Development | Profile | |
| Mark Luscher | Senior Vice President - Scientific Affairs | Profile | |
| Christopher Lobb | General Officer | Profile | |
| Phillip Casselli | Senior Development | Profile |
About Microbix Biosystems Management Performance
The success or failure of an entity such as Microbix Biosystems often depends on how effective the management is. Microbix Biosystems management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Microbix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Microbix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | (0.04) | (0.04) | |
| Return On Assets | (0.05) | (0.06) | |
| Return On Equity | (0.07) | (0.08) |
Microbix Biosystems Workforce Analysis
Traditionally, organizations such as Microbix Biosystems use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Microbix Biosystems within its industry.Microbix Biosystems Manpower Efficiency
Return on Microbix Biosystems Manpower
| Revenue Per Employee | 1.2M | |
| Revenue Per Executive | 1.2M | |
| Net Loss Per Employee | 149.7K | |
| Net Loss Per Executive | 149.7K | |
| Working Capital Per Employee | 1.4M | |
| Working Capital Per Executive | 1.4M |
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.